Evidence map›Paper›PMID 38259076›Full record

ArticleApplied and environmental microbiology2024

β-1,3-Glucan recognition by

Marina da Silva Ferreira, Diego de Souza Gonçalves, Susana Ruiz Mendoza, Gabriel Afonso de Oliveira, Bruno Pontes, Claudia Rodríguez-de la Noval, Leandro Honorato, Luis Felipe Costa Ramos, Fábio C S Nogueira, Gilberto B Domont and 4 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied and environmental microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Interactions of the emerging fungusMicrobiology spectrum · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Marina da Silva Ferreira *Laboratório de Bioquímica e Imunologia das Micoses, Departamento de Microbiologia e Parasitologia, Instituto Biomédico, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.
Diego de Souza Gonçalves *Programa de Pós-Graduação em Doenças Infecciosas e Parasitárias, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Niterói, Rio de Janeiro, Brazil.
Susana Ruiz MendozaLaboratório de Bioquímica e Imunologia das Micoses, Departamento de Microbiologia e Parasitologia, Instituto Biomédico, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.
Gabriel Afonso de OliveiraLaboratório de Bioquímica e Imunologia das Micoses, Departamento de Microbiologia e Parasitologia, Instituto Biomédico, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.
Bruno PontesInstituto de Ciências Biomédicas e Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Niterói, Rio de Janeiro, Brazil.
Claudia Rodríguez-de la NovalLaboratório de Bioquímica e Imunologia das Micoses, Departamento de Microbiologia e Parasitologia, Instituto Biomédico, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.
Leandro HonoratoLaboratório de Glicobiologia de Eucariotos, Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Niterói, Rio de Janeiro, Brazil.
Luis Felipe Costa RamosDepartamento de Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro, Niterói, Rio de Janeiro, Brazil.
Fábio C S NogueiraDepartamento de Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro, Niterói, Rio de Janeiro, Brazil.
Gilberto B DomontDepartamento de Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro, Niterói, Rio de Janeiro, Brazil.
Arturo CasadevallDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-9402-9167
Leonardo NimrichterPrograma de Pós-Graduação em Imunologia e Inflamação, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Niterói, Rio de Janeiro, Brazil.
Jose Mauro PeraltaPrograma de Pós-Graduação em Doenças Infecciosas e Parasitárias, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Niterói, Rio de Janeiro, Brazil.
Allan J GuimaraesLaboratório de Bioquímica e Imunologia das Micoses, Departamento de Microbiologia e Parasitologia, Instituto Biomédico, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.ORCID 0000-0002-2856-9667
Universidade Federal do Rio de Janeiro · BRJohns Hopkins University · USUniversidade Federal Fluminense · BR

Funding

Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 311470/2018-1, 309736/2021-8Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) E-26/200.997/2022NHLBI NIH HHS R01 HL059842
6 · The paper itself

Abstract

In this study, we conducted an in-depth analysis to characterize potential

Indexed as

Acanthamoeba castellaniiAmoebabeta-GlucansGlucansHistoplasmaMannoseProteomicsbeta-1,3-glucanbeta-GlucansGlucansMannoseAcanthamoeba castellaniiHistoplasma capsulatuminteractionmacrophageβ-glucan

Identifiers

PMID38259076
PMCPMC10880599
OpenAlexW4391135866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.